Evidence map›Paper›PMID 33431694›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Altered ratio of dendritic cell subsets in skin-draining lymph nodes promotes Th2-driven contact hypersensitivity.

Hannah L Miller, Prabhakar Sairam Andhey, Melissa K Swiecki, Bruce A Rosa, Konstantin Zaitsev, Alexandra-Chloe Villani, Makedonka Mitreva, Maxim N Artyomov, Susan Gilfillan, Marina Cella and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Role of Innate Immunity in Allergic Contact Dermatitis: An Update.International journal of molecular sciences · 2023
    Review
  7. Antioxidants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Hannah L MillerDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-5137-2678
Prabhakar Sairam AndheyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Melissa K SwieckiDiscovery Immunology, Janssen Research & Development, Spring House, PA 19477.
Bruce A RosaDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
Konstantin ZaitsevDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Alexandra-Chloe VillaniCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0001-7461-0408
Makedonka MitrevaDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0001-9572-3436
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Susan GilfillanDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0003-1672-0996
Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0003-1230-1313
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; mcolonna@wustl.edu.ORCID 0000-0001-5222-4987
Washington University in St. Louis · USJames S. McDonnell Foundation · USITMO University · RUJanssen (United States) · USMassachusetts General Hospital · US

Funding

Elucidating the tolerogenic roles of plasmacytoid dendritic cells in the gastrointestinal system.F30DK112508 · NIDDK · WASHINGTON UNIVERSITY · PI MILLER, HANNAH LEIGH · 2016 to 2019
$160k
NIDDK NIH HHS F30 DK112508
6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) specialize in the production of type I IFN (IFN-I). pDCs can be depleted in vivo by injecting diphtheria toxin (DT) in a mouse in which pDCs express a diphtheria toxin receptor (DTR) transgene driven by the human CLEC4C promoter. This promoter is enriched for binding sites for TCF4, a transcription factor that promotes pDC differentiation and expression of pDC markers, including CLEC4C. Here, we found that injection of DT in CLEC4C-DTR

Indexed as

AnimalsAntigens, CDCell LineageDendritic CellsDermatitis, ContactDiphtheria ToxinHeparin-binding EGF-like Growth FactorHumansIntegrin alpha ChainsInterferon Type ILectins, C-TypeLymph NodesMiceMice, Inbred C57BLPromoter Regions, GeneticReceptors, Immunologicalpha E integrinsAntigens, CDClec4d protein, mouseDiphtheria ToxinHeparin-binding EGF-like Growth FactorIntegrin alpha ChainsInterferon Type ILectins, C-TypeReceptors, ImmunologicTcf4 protein, mouseTranscription Factor 4allergycontact hypersensitivityplasmacytoid DCskinTh2

Identifiers

PMID33431694
PMCPMC7826349
OpenAlexW3120126856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.